CHEMED CORP (CHE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 900M 1.8B 2.7B FY08: 1.1B FY09: 1.2B FY10: 1.3B FY11: 1.4B FY12: 1.4B FY13: 1.4B FY14: 1.5B FY15: 1.5B FY16: 1.6B FY17: 1.7B FY18: 1.8B FY19: 1.9B FY20: 2.1B FY21: 2.1B FY22: 2.1B FY23: 2.3B FY24: 2.4B FY25: 2.5B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 300M 600M 900M FY12: 396.7M FY13: 404.5M FY14: 421.6M FY15: 455.8M FY16: 461.4M FY17: 516.2M FY18: 555M FY19: 617.4M FY20: 701.4M FY21: 769.8M FY22: 765.1M FY23: 798.8M FY24: 854.3M FY25: 823.2M FY13 FY15 FY17 FY19 FY21 FY23 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

0 150M 300M 450M FY08: 132.9M FY09: 126.3M FY10: 143.5M FY11: 153.7M FY12: 156.4M FY13: 133.4M FY14: 168.4M FY15: 184.5M FY16: 178.7M FY17: 113M FY18: 243.6M FY19: 257.4M FY20: 389.7M FY21: 343M FY22: 343.5M FY23: 340.6M FY24: 366.5M FY25: 338.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

0 150M 300M 450M FY08: 67.3M FY09: 73.8M FY10: 81.8M FY11: 86M FY12: 89.3M FY13: 77.2M FY14: 99.3M FY15: 110.3M FY16: 108.7M FY17: 98.2M FY18: 205.5M FY19: 219.9M FY20: 319.5M FY21: 268.6M FY22: 249.6M FY23: 272.5M FY24: 302M FY25: 265.2M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 600M 1.2B 1.8B FY08: 810.5M FY09: 834.6M FY10: 906M FY11: 970.5M FY12: 1B FY13: 1B FY14: 1B FY15: 1.1B FY16: 1.1B FY17: 1.2B FY18: 1.2B FY19: 1.3B FY20: 1.4B FY21: 1.4B FY22: 1.4B FY23: 1.5B FY24: 1.6B FY25: 1.7B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 200M 400M 600M FY08: 112.1M FY09: 160.8M FY10: 86M FY11: 174.3M FY12: 131.8M FY13: 150.8M FY14: 110.3M FY15: 171.5M FY16: 135.4M FY17: 162.5M FY18: 287.1M FY19: 301.2M FY20: 489.3M FY21: 308.6M FY22: 309.9M FY23: 330.3M FY24: 417.5M FY25: 388.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 150M 300M 450M FY08: 86M FY09: 139.3M FY10: 60.4M FY11: 144.8M FY12: 96.5M FY13: 121.5M FY14: 66.7M FY15: 127.4M FY16: 95.6M FY17: 98.2M FY18: 234.3M FY19: 248.2M FY20: 430.5M FY21: 249.9M FY22: 252.6M FY23: 273.4M FY24: 368M FY25: 325.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 8M 16M 24M FY08: 23.4M FY09: 22.7M FY10: 23M FY11: 20.9M FY12: 19.3M FY13: 18.6M FY14: 17.8M FY15: 17.4M FY16: 16.8M FY17: 16.7M FY18: 16.8M FY19: 16.5M FY20: 16.4M FY21: 15.9M FY22: 15.1M FY23: 15.2M FY24: 15.2M FY25: 14.5M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 7.00 14.00 21.00 Q4 '09: 3.24 Q1 '10: 3.22 Q2 '10: 3.56 Q3 '10: 3.63 Q4 '10: 3.83 Q1 '11: 3.83 Q2 '11: 3.67 Q3 '11: 3.80 Q4 '11: 4.10 Q1 '12: 4.32 Q2 '12: 4.48 Q3 '12: 4.51 Q4 '12: 4.62 Q1 '13: 4.73 Q2 '13: 4.40 Q3 '13: 4.27 Q4 '13: 4.15 Q1 '14: 4.10 Q2 '14: 4.69 Q3 '14: 5.14 Q4 '14: 5.57 Q1 '15: 5.85 Q2 '15: 6.04 Q3 '15: 6.30 Q4 '15: 6.32 Q1 '16: 6.37 Q2 '16: 6.30 Q3 '16: 6.27 Q4 '16: 6.49 Q1 '17: 6.82 Q2 '17: 3.99 Q3 '17: 4.50 Q4 '17: 5.82 Q1 '18: 6.70 Q2 '18: 11.32 Q3 '18: 12.25 Q4 '18: 12.24 Q1 '19: 12.28 Q2 '19: 12.09 Q3 '19: 12.59 Q4 '19: 13.30 Q1 '20: 13.98 Q2 '20: 15.91 Q3 '20: 16.49 Q4 '20: 19.48 Q1 '21: 20.11 Q2 '21: 18.61 Q3 '21: 19.02 Q4 '21: 16.86 Q1 '22: 17.07 Q2 '22: 17.96 Q3 '22: 17.19 Q4 '22: 16.52 Q1 '23: 15.88 Q2 '23: 14.99 Q3 '23: 16.14 Q4 '23: 17.93 Q1 '24: 18.59 Q2 '24: 19.73 Q3 '24: 19.80 Q4 '24: 19.90 Q1 '25: 20.52 Q2 '25: 19.44 Q3 '25: 18.90 Q4 '25: 18.34 Q1 '26: 18.32 Q2 '26: 19.88 Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.